Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AZN | AMGN | GILD | VRTX |
| Company | Bristol-Myers Squibb Company | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 59.79 | 207.30 | 357.46 | 142.38 | 446.08 |
| High | 59.80 | 207.30 | 357.46 | 142.38 | 446.75 |
| Low | 58.61 | 204.33 | 351.24 | 139.76 | 436.25 |
| Latest | 58.97 | 204.70 | 352.63 | 140.74 | 438.24 |
| Change | -0.50 | -0.29 | -2.97 | -1.35 | -8.54 |
| % Change | -0.84% | -0.14% | -0.84% | -0.95% | -1.91% |
| Volume | 2,423,254 | 782,235 | 601,666 | 1,140,613 | 366,154 |
| 20-Day Average Volume | 13,067,535 | 1,824,676 | 2,659,244 | 5,739,536 | 1,317,095 |
| Previous Close | 59.47 | 204.99 | 355.60 | 142.09 | 446.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.04 | 193.79 | 351.97 | 139.91 | 448.65 |
| 20-Day Raw Stochastic | 39.83% | 88.98% | 46.10% | 48.08% | 19.61% |
| 20-Day Relative Strength | 49.13 | 59.87 | 47.90 | 49.58 | 43.52 |
| Weighted Alpha | +22.05 | +53.63 | +24.18 | +35.55 | -6.54 |
| Today's Opinion | 48% Buy | 88% Buy | 56% Buy | 56% Buy | 24% Sell |
| Previous Opinion | 64% Buy | 88% Buy | 56% Buy | 56% Buy | 8% Buy |
| Last Month's Opinion | 88% Buy | 64% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.43% since 04/02/26 | +0.52% since 04/02/26 | +1.32% since 04/02/26 | +0.77% since 04/02/26 | -0.32% since 04/02/26 |
| Low | 57.65 on 04/07/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 425.26 on 04/07/26 |
| High | 59.79 on 04/10/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 447.00 on 04/09/26 |
| 1-Month | |||||
| %Chg | -2.30% since 03/10/26 | +4.91% since 03/10/26 | -6.10% since 03/10/26 | -5.24% since 03/10/26 | -12.39% since 03/10/26 |
| Low | 56.45 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 425.26 on 04/07/26 |
| High | 62.22 on 04/01/26 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 499.49 on 03/11/26 |
| 3-Month | |||||
| %Chg | +5.17% since 01/09/26 | +8.06% since 01/09/26 | +8.11% since 01/09/26 | +16.25% since 01/09/26 | -5.73% since 01/09/26 |
| Low | 53.54 on 01/21/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 425.26 on 04/07/26 |
| High | 62.89 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +33.64% since 10/10/25 | +21.00% since 10/10/25 | +21.51% since 10/10/25 | +20.14% since 10/10/25 | +7.24% since 10/10/25 |
| Low | 42.52 on 10/29/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 62.89 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 121,421,984 | 317,920,640 | 191,911,984 | 176,365,248 | 113,642,960 |
| Shares Outstanding, K | 2,041,735 | 1,550,908 | 539,685 | 1,241,222 | 254,360 |
| Annual Sales | 48,194,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 7,054,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 12,502,000,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | 1,086,000,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.27 | 0.35 | 0.47 | 0.39 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.26 on 02/05/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 04/30/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | 0.630 on 04/02/26 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | 04/02/26 | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 9.63 | 22.30 | 16.01 | 17.37 | 27.04 |